Skip to main content

BARCLAYS PLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,773,976
-$6,946,004 QoQ
Shares Held
52,438
-83.6% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Dec 31, 2025
CallValue
$1,420,884
CallShares
52,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. AGIO ranks #75 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,773,976 52,438
2025-12-31 $8,719,980 320,352
2025-12-31 $1,420,884 52,200
2025-09-30 $8,671,844 216,040
2025-06-30 $6,010,212 180,704
2025-03-31 $3,315,382 113,153
2024-12-31 $4,000,803 121,753
2024-09-30 $8,015,927 180,417
2024-09-30 $1,430,646 32,200
2024-06-30 $1,388,464 32,200
2024-06-30 $4,738,068 109,881
2024-03-31 $877,200 30,000
2024-03-31 $877,200 30,000
2024-03-31 $2,024,168 69,226
2023-12-31 $1,336,200 60,000
2023-12-31 $1,336,200 60,000
2023-12-31 $3,445,970 154,736
2023-09-30 $2,994,947 121,008
2023-06-30 $4,495,091 158,725
2023-03-31 $2,201,192 95,829
2022-12-31 $3,600,136 128,210
2022-09-30 $2,700,739 95,500
2022-06-30 $430,541 19,420
2022-03-31 $1,917,766 65,880
2021-12-31 $2,294,819 69,815
2021-09-30 $1,219,467 26,424
2021-06-30 $2,941,661 53,378
2021-03-31 $4,782,844 92,619
2020-12-31 $4,828,954 111,446
2020-09-30 $4,014,465 114,699
2020-06-30 $5,672,730 106,072
2020-03-31 $3,903,118 110,009